Below is a list of the “active” grants of the Flinn Foundation—those grants that have been awarded and have yet to receive final payment; and/or for which grant-related activities have not concluded.
Many Flinn Foundation grants are multi-year awards that receive payments at several junctures. In some cases, grants are extended (without additional funding) beyond their scheduled date of conclusion.
This list is not comprehensive, as it excludes modest grants for membership dues to philanthropic organizations and other miscellaneous awards, but represents the Foundation’s project-specific grant-making activity to achieve its strategic goals.
Search
Tucson Symphony Orchestra
City:
Amount: 300,000
Award Date: 2024
Duration: 36 months
Program Area: Arts and Culture
Support for a project advancing organizational goals in the “post-pandemic” period. This grant, awarded under the Foundation’s arts-and-culture Initiative for Financial and Creative Health, will involve close examination of the organization’s capitalization strategies.
University of Arizona
City:
Amount: 100,000
Award Date: 2026
Duration: 12 months
Program Area: Bioscience
Translational Seed Grant: Follow-on funding to develop diagnostic tools for cardiovascular disease. The team aims to develop a predictive assay for chronic ischemic heart failure, where smarter biomarkers can enable more targeted therapies. Follow-on funds will be used to develop a predictive assay in heart failure patients, filing additional IP for peripheral profiles in the process.
University of Arizona
City:
Amount: 100,000
Award Date: 2026
Duration: 18 months
Program Area: Bioscience
Translational Seed Grant: Endometrial cancer is the most prevalent gynecologic malignancy in the United States and Arizona, with incidence and mortality rates continuing to rise. Current diagnostic procedures, such as dilation and curettage or endometrial biopsy, are invasive, costly, and often inaccessible. The team is developing a non-invasive diagnostic platform leveraging cervicovaginal sampling and biomarker analysis for detection. Their custom multiplex biomarker assay optimized for clinical implementation aims to reduce diagnostic delays and improve outcomes for women.
University of Arizona
City:
Amount: 50,000
Award Date: 2026
Duration: 18 months
Program Area: Bioscience
Currently, the only way to determine if a person has schizophrenia is through a psychiatric evaluation. A major reason that no biomarkers for schizophrenia have been identified is that the organ responsible for the illness, the brain, is not accessible. This team has identified a way to detect abnormal function of genes essential for brain development and function from a blood sample for use in diagnosing schizophrenia.
University of Arizona
City:
Amount: 660,000
Award Date: 2025
Duration: 48 months
Program Area: Flinn Scholars
Scholarship awards for members of the Flinn Scholars Class of 2025.